Moracin E



Compound IDCDAMM00853
Common nameMoracin E
IUPAC name5-(6-hydroxy-1-benzofuran-2-yl)-2,2-dimethylchromen-7-ol
Molecular formulaC19H16O4

Experimental data

Retention time0.45
Adduct[M+K]+
Actual mz347.071
Theoretical mz347.068
Error8.19
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score7.7397

Identifiers and class information

Inchi keyGDSYWTBPYYYLLE-UHFFFAOYSA-N
SmilesOC=1C=CC=2C=C(OC2C1)C=3C=C(O)C=C4OC(C=CC43)(C)C
SuperclassPhenylpropanoids and polyketides
Class2-arylbenzofuran flavonoids

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)2
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)0
Molecular weight (mol_MW)308.333
Computed dipole moment(dipole)1.514
Total solvent accessible surface area (SASA)573.691
Hydrophobic component of SASA (FOSA)153.467
Hydrophilic component of SASA (FISA)109.03
Pie component of the SASA (PISA)311.194
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)984.66
Number of hydrogen bond donors (donorHB)2
Number of hydrogen bond acceptors (accptHB)2.75
Free energy of solvation of dipole (dip^2/V)0.0023282
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0067791
Globularity descriptor (glob)0.834344
Predicted polarizability in cubic angstroms (QPpolrz)34.94
Predicted hexadecane/gas partition coefficient (QPlogPC16)10.727
Predicted octanol/gas partition coefficient (QPlogPoct)15.901
Predicted water/gas partition coefficient (QPlogPw)9.155
Predicted octanol/water partition coefficient (QPlogPo/w)3.624
Predicted aqueous solubility (QPlogS)-5.2
Conformation-independent predicted aqueous solubility (CIQPlogS)-5.317
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.697
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)916.146
Predicted brain/blood partition coefficient (QPlogBB)-0.601
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)450.027
Predicted skin permeability, log Kp (QPlogKp)-2.241
PM3 calculated ionization potential (IP(ev))8.446
PM3 calculated electron affinity (EA(eV))0.828
Number of likely metabolic reactions (#metab)3
Prediction of binding to human serum albumin (QPlogKhsa)0.58
Predicted qualitative human oral absorption (HumanOralAbsorption)3
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)100
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)57.511
Number of nitrogen and oxygen atoms (#NandO)4
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)0

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P42336PIK3CAPI3-kinase p110-alpha subunitT80276SwissTargetPrediction
P11926ODC1Ornithine decarboxylaseT60366SEA
P21964COMTCatechol O-methyltransferase (by homology)T76904SwissTargetPrediction
P14061HSD17B1Estradiol 17-beta-dehydrogenase 1T44011SwissTargetPrediction
Q08499PDE4DPhosphodiesterase 4DT02001SEA
P25101EDNRAEndothelin receptor ET-AT23499SwissTargetPrediction
Q07912TNK2Tyrosine kinase non-receptor protein 2T63220SwissTargetPrediction
P48736PIK3CGPI3-kinase p110-gamma subunitT95913SwissTargetPrediction
P15056BRAFSerine/threonine-protein kinase B-rafT99089SwissTargetPrediction
P14679TYRTyrosinaseT97035SEA
P00374DHFRDihydrofolate reductaseT17345SwissTargetPrediction
Q9NZ08ERAP1Endoplasmic reticulum aminopeptidase 1T72849SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T80276DI0062Breast cancer[ICD-11: 2C60-2C6Y]P42336PIK3CA
T80276DI0151Follicular lymphoma[ICD-11: 2A80]P42336PIK3CA
T80276DI0245Malignant haematopoietic neoplasm[ICD-11: 2B33]P42336PIK3CA
T60366DI0020African trypanosomiasis[ICD-11: 1F51]P11926ODC1
T76904DI0331Parkinsonism[ICD-11: 8A00]P21964COMT
T02001DI0411Tonus and reflex abnormality[ICD-11: MB47]Q08499PDE4D
T23499DI0070Cardiovascular disease[ICD-11: BA00-BE2Z]P25101EDNRA
T23499DI0356Pulmonary hypertension[ICD-11: BB01]P25101EDNRA
T23499DI0425Urinary system clinical symptom[ICD-11: MF8Y]P25101EDNRA
T95913DI0151Follicular lymphoma[ICD-11: 2A80]P48736PIK3CG
T95913DI0245Malignant haematopoietic neoplasm[ICD-11: 2B33]P48736PIK3CG
T95913DI0249Mature B-cell leukaemia[ICD-11: 2A82]P48736PIK3CG
T99089DI0252Melanoma[ICD-11: 2C30]P15056BRAF
T97035DI0007Acquired hypermelanosis[ICD-11: ED60]P14679TYR
T97035DI0008Acquired hypomelanotic disorder[ICD-11: ED63]P14679TYR
T17345DI0207Indeterminate colitis[ICD-11: DD72]P00374DHFR
T17345DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P00374DHFR
T17345DI0416Tuberculosis[ICD-11: 1B10-1B12]P00374DHFR
T17345DI0427Urinary tract infection[ICD-11: GC08]P00374DHFR

Copyright © 2025